BARABINO SILVIA MARIA LUISA

Zerbato, B., Brancato, V., Giampà, M., Taverna, G., Monterosso, G., Taglietti, L., et al. (2025). Hexosamine Pathway inhibition: one molecule able to induce a Brcaness phenotype as promising cancer therapy. Intervento presentato a: BtBs day 2025 – Giornata del Dipartimento di Biotecnologie e Bioscienze - UNIMIB, University of Milano-Bicocca, Milan, Italy. Detail

Zerbato, B., Brancato, V., Giampà, M., Taverna, G., Monterosso, G., Taglietti, L., et al. (2025). PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells. Intervento presentato a: 17th PhD meeting TeCSBi, University of Milano-Bicocca, Milan, Italy. Detail

Zerbato, B., Brancato, V., Giampà, M., Taverna, G., Monterosso, G., Taglietti, L., et al. (2025). Hexosamine Biosynthetic Pathway inhibition sensitizes pancreatic cancer cells to DNA damage. Intervento presentato a: Cancer Research Day - Syöpätutkimuspäivä 2025 - 12.3.2025, Tampere, Finland. Detail

Zerbato, B., Brancato, V., Giampà, M., Taverna, G., Monterosso, G., Taglietti, L., et al. (2025). PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells. Intervento presentato a: 63th SIB Congress - September 10-12, 2025, Palermo, Italy. Detail

Lombardi, S., Zilocchi, M., Nicsanu, R., Barabino, S. (2025). Emerging connections: Poly(ADP-ribose), FET proteins and RNA in the regulation of DNA damage condensates. DNA REPAIR, 150(June 2025) [10.1016/j.dnarep.2025.103846]. Detail